Subject: [jats-list] JATS4R permissions recommendation revision|
From: "Melissa Harrison m.harrison@xxxxxxxxxxxxxxxxx" <jats-list-service@xxxxxxxxxxxxxxxxxxxxxx>
Date: Thu, 4 Jan 2018 16:11:53 -0000
Hi there I was hoping for some feedback from the community on the JATS4R steering committee's potential revision to the Permissions recommendation <https://jats4r.org/permissions>. It currently lists <copyright-year> and <copyright-holder> as required tags, but we have found some use cases where these are not required or even not actually allowed, and so are proposing updating the recommendation to make these elements optional. *Use case 1 - Authors work for government organizations* - Open Access content: Some authors working for government organizations waiver their right to copyright, and use of a CC0 <https://creativecommons.org/choose/zero/> license is used. - For subscription journals, the copyright is waivered and there is a non-exclusive license (publisher and government) - generally a non-machine readable/standard license *Use case 2 - Rather than add "The authors" in the copyright holder line, some publishers just omit it* Some publishers would not list out the names of the authors in the copyright-holder tag, and rather than add "The authors" just omit the copyright holder line. Does anyone have any feedback to JATS4R on this and do you agree? Thanks Melissa (on-behalf of the JATS4R Steering Committee) -- Melissa Harrison, Head of Production Operations, *eLife* eLife Sciences Publications, Ltd 1st Floor 24 Hills Road Cambridge CB2 1JP 01223 855345 orcid.org/0000-0003-3523-4408 Receive content alerts <http://www.elifesciences.org/crm/civicrm/profile/create> Browse articles <http://elife.elifesciences.org/browse> eLife Sciences Publications, Ltd is a limited liability non-profit non-stock corporation incorporated in the State of Delaware, USA, with company number 5030732, and is registered in the UK with company number FC030576 and branch number BR015634 at the address First Floor, 24 Hills Road, Cambridge CB2 1JP.